NewsBenzinga애큐먼 파마, 알츠하이머 임상시험에서 ALTITUDE-AD가 1차 및 주요 2차 평가 지표 달성 실패 발표···사비르네투그 임상 개발 중단, 현금 보유 및 전략적 옵션 모색 예정 애큐먼 파마, 알츠하이머 임상시험에서 ALTITUDE-AD가 1차 및 주요 2차 평가 지표 달성 실패 발표···사비르네투그 임상 개발 중단, 현금 보유 및 전략적 옵션 모색 예정 Benzinga 2026.10.30 11:13 (GMT+0) Open on Benzinga Other news Analysis: Hyperliquid's Stock and Commodity Trading Revenue Grows 6x, Reducing Reliance on Crypto Market Grayscale: Multiple Factors Have Turned Crypto Valuations Oversold; Current Levels Are a Medium- to Long-Term Buying Opportunity for Bitcoin Bitcoin Lightning Network Developers Patch LND Flaw That Could Wipe Payment Records After Node Restart Canton Strategic Holdings Q3 Revenue of $3.05M, Net Loss Widens to $35.1M StablecoinX Q3 Revenue Reaches $478,000, Net Loss $100 Million Nvidia Employee Letter to Board Warns Company Faces Talent Loss If Huang Isn't Reinstated as CEO
Analysis: Hyperliquid's Stock and Commodity Trading Revenue Grows 6x, Reducing Reliance on Crypto Market
Grayscale: Multiple Factors Have Turned Crypto Valuations Oversold; Current Levels Are a Medium- to Long-Term Buying Opportunity for Bitcoin
Bitcoin Lightning Network Developers Patch LND Flaw That Could Wipe Payment Records After Node Restart